Westport’s Intensity Therapeutics gains ground with potential game changing cancer treatment. Armed with a pair of U.S. patents and some $13 million in investments, Intensity Therapeutics Inc. in Westport has started clinical trials on what its founder maintains could be a game-changer in the treatment of cancer. “I looked at the problem from an engineer’s perspective,” said Lew Bender, Intensity Therapeutics president and CEO, at his biotech company’s 61 Wilton Road headquarters. “And what I wanted to do had three restrictions: killing big tumors without invasive surgery, getting rid of the small cancer cells that can’t be seen by the naked eye, and cutting back on the toxicity” associated with chemotherapy and similar treatments. The key, Bender said, was developing an immuno-oncology approach, an area of research that enlists and engineers the body’s own immune system to fight cancer.

Source: Fairfield County Business Journal